The exploration of psychedelics in mental health is a burgeoning field, daring to reshape the landscape of traditional therapy. At the forefront of this paradigm shift are clinicians pioneering an integrative approach to addiction and chronic pain management. Through a fusion of pharmacology with holistic measures trailblazers, such as Dr. Howard Kornfeld and Inna Zelikman of Recovery Without Walls, are unlocking transformative healing possibilities within psychedelic-assisted therapies.

In Part two of our conversation we lead further into the nuance of dosing - a cornerstone for the efficacy of ketamine-assisted therapy. Kornfeld and Zelikman describe their methodical process, a precise titration starting from 0.5 milligrams per kilogram and adjusting according to individual responses. "We can, you know, set the right dose for a patient to have that psychedelic experience," Ina Zelikman explains, shedding light on the careful personalization that dictates the journey's course. This emphasis on individualization underscores the critical role of the patient-clinician dynamic and the imperative of adapting each treatment to unique physiological and psychological landscapes.